Modulation of renal-specific oxidoreductase/myo-inositol oxygenase by high-glucose ambience.
Biological properties of renal-specific oxidoreductase (RSOR), characteristics of its promoter, and underlying mechanisms regulating its expression in diabetes were analyzed. RSOR expression, normally confined to the renal cortex, was markedly increased and extended into the outer medullary tubules in db/db mice, a model of type 2 diabetes. Exposure of LLCPK cells to d-glucose resulted in a dose-dependent increase in RSOR expression and its enzymatic activity. The latter was related to one of the glycolytic enzymes, myo-inositol oxygenase. The increase in activity was in proportion to serum glucose concentration. The RSOR expression also increased in cells treated with various organic osmolytes, e.g., sorbitol, myoinositol, and glycerolphosphoryl-choline and H(2)O(2). Basal promoter activity was confined to -1,252 bp upstream of ATG, and it increased with the treatment of high glucose and osmolytes. EMSAs indicated an increased binding activity with osmotic-, carbohydrate-, and oxidant-response elements in cells treated with high glucose and was abolished by competitors. Supershifts, detected by anti-nuclear factor of activated T cells, and carbohydrate-response-element-binding protein established the binding specificity. Nuclear factor of activated T cells tonicity-enhancer-binding protein and carbohydrate-response-element-binding protein had increased nuclear expression in cells treated with high glucose. The activity of osmotic-response element exhibited a unique alternate binding pattern, as yet unreported in osmoregulatory genes. Data indicate that RSOR activity is modulated by diverse mechanisms, and it is endowed with dual properties to channel glucose intermediaries, characteristic of hepatic aldehyde reductases, and to maintain osmoregulation, a function of renal medullary genes, e.g., aldose reductase, in diabetes.
Nayak
Baibaswata
B
Department of Pathology, Northwestern University Medical School, Chicago, IL 60611, USA.
Xie
Ping
P
Akagi
Shigeru
S
Yang
Qiwei
Q
Sun
Lin
L
Wada
Jun
J
Thakur
Arun
A
Danesh
Farhad R
FR
Chugh
Sumant S
SS
Kanwar
Yashpal S
YS
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D015152:Blotting, Northern; D015153:Blotting, Western; D002478:Cells, Cultured; D017931:DNA Primers; D003924:Diabetes Mellitus, Type 2 / Q000201:enzymology*; D024202:Electrophoretic Mobility Shift Assay; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects*; D005947:Glucose / Q000494:pharmacology; D006861:Hydrogen Peroxide / Q000494:pharmacology; D007294:Inositol / Q000494:pharmacology; D050562:Inositol Oxygenase / Q000378:metabolism*; D007668:Kidney / Q000378:metabolism*; D008156:Luciferases; D008297:Male; D051379:Mice; D016688:Mice, Inbred NOD; D010088:Oxidoreductases / Q000235:genetics / Q000378:metabolism*; D020218:Response Elements / Q000502:physiology; D013012:Sorbitol / Q000494:pharmacology; D013379:Substrate Specificity; D014162:Transfection; D014882:Water-Electrolyte Balance / Q000502:physiology*
D001786:Blood Glucose; D017931:DNA Primers; D007294:Inositol; D013012:Sorbitol; D006861:Hydrogen Peroxide; D010088:Oxidoreductases; D008156:Luciferases; D050562:Inositol Oxygenase; D005947:Glucose